highly significantP < 0.001
Post-challenge, liver TAC displayed a highly significant enhancement ( P < 0.001) in the DBSFM -treated groups compared to the control.
Post-challenge, liver TAC displayed a highly significant enhancement ( P < 0.001) in the DBSFM -treated groups compared to the control.